Advanced Management of OAB and NDO with Onabotulinum Toxin

We are pleased to invite you to our Advance Management of OAB and NDO with Intravesical Onabotulinum Toxin s t u d y d a y at University
College Hospital in London. This session will include the management of OAB and the practicalities of using Onabotulinum toxin type A in patients with idiopathic detrusor activity (IDO) and neurogenic detrusor overactivity (NDO). As part of the day we will be discussing the best
service model for patients and HCPs, whilst also looking to the future management of this patient population in the post COVID era.

This is free event for delegates. If you are interested then apply via the application link below

https://forms.office.com/e/M1dDjaBAih